The COVID-19 vaccine was a triumph of science. Governments, researchers, and vaccine manufacturers worked in tandem to ...

SK bioscience, PATH, Slalom, and SK AX will jointly develop an AI-powered platform for evidence-based clinical development decision-making. The project will support next-generation injectable ...

Artificial intelligence has been used to develop a "fundamentally new" type of vaccine that could protect against large swathes of viruses and prevent pandemics, say researchers. The team at the ...

New preclinical data will guide antigen selection for a broadly protective cytomegalovirus vaccine candidatePoster presentation on July 12, 2026, ...

Qualified Vero Master Cell Bank and Working Cell Bank, originating from WHO banks, are available for purchase, licensing, and use in ...

Research led by the University of Bergen (UiB) and NORCE may help pave the way for a new vaccine targeting one of the world's leading causes of severe diarrheal disease. The technology has now been ...

The vaccine, intended for people 50 and older, is based on mRNA technology and was found in an advanced trial to be more ...

A comprehensive new review published in The Lancet affirms that currently approved mRNA vaccines are safe and highly ...

As Gavi prepares the first payouts from its $1.2 billion manufacturing program, the challenge shifts from financing factories ...

Forbes contributors publish independent expert analyses and insights. Christine Ro is a journalist covering science and development. This voice experience is generated by AI. Learn more. This voice ...

Preclinical study demonstrates effectiveness of experimental mRNA vaccine against neuroblastoma, reducing tumour size by 70 ...